Lantern Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,800
Closed -$255K 138
2024
Q3
$255K Sell
3,800
-500
-12% -$41.1K 0.18% 109
2024
Q2
$488K Buy
4,300
+200
+5% +$25.3K 0.35% 70
2024
Q1
$569K Buy
4,100
+200
+5% +$25.1K 0.4% 64
2023
Q4
$484K Buy
+3,900
New +$398K 0.38% 66

Other funds holding DXCM

Lantern Wealth Advisors's DXCM Position: Q4 2024 in Review

Lantern Wealth Advisors sold out of DexCom (DXCM) in Q4 2024, closing a stake of 3,800 shares — an estimated $255K sold.

Lantern Wealth Advisors first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $569K in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Lantern Wealth Advisors reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Lantern Wealth Advisors sold 3,800 DexCom shares in Q4 2024, an estimated $255K.
  • Lantern Wealth Advisors first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
  • Lantern Wealth Advisors's DexCom position peaked at $569K in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Lantern Wealth Advisors's 13F filing for Q4 2024, filed 18 Feb 2025.